Pharma AI consultancy, Ireland
Glyz helps pharmaceutical and life sciences companies in Ireland and across Europe decide where AI is worth using, put the right governance around it and turn pilots into everyday practice. Every use case is designed around the review, data protection and quality requirements your teams already work under.
In brief
Pharma AI consultancy helps pharmaceutical and life sciences companies choose, govern and adopt AI in a way that fits regulated work. It covers which use cases are worth pursuing, whether data, processes and people are ready, how outputs are checked and approved, and how a pilot becomes part of everyday work.
The difference from general AI consulting is the setting: promotional content passes medical, legal and regulatory review, personal and health data carry strict obligations under GDPR, and the EU AI Act adds requirements depending on how a system is used. Glyz plans AI around these rules from the start, working with your compliance and legal teams rather than around them.
What we do
Start with a single assessment or run the whole programme with us.
We map where AI could help commercial, medical, digital and operations teams, and score each idea for value, feasibility and risk.
A clear view of where AI is worth the effort, and where it is not.
We review data, processes, people and controls, then design the governance needed for the use cases you choose.
AI used with confidence, with a clear record of how outputs are checked.
AI-assisted workflows that help teams draft, adapt and check content while approved claims and human review stay in control.
Faster content work without bypassing medical, legal and regulatory review.
We help move AI from a pilot into everyday use, with training, change support and measures that show whether it is working.
AI that people actually use, not another stalled pilot.
How we work
We review your goals, workflows, data and controls, and agree where AI could help.
We score the options and agree a short list with your leadership and compliance teams.
We design the review, approval and data protection rules for the chosen use cases.
We run a scoped pilot with clear measures and real users.
We support training and change so the use case becomes everyday practice.
Why Glyz
Glyz combines AI strategy with the design, content and development work pharma teams do every day, so recommendations are grounded in how review, content and systems actually work. When you are ready to build, the same team can deliver the solution and the training.
Read the AI readiness assessment case study ›Questions
Advice and hands-on support that helps pharmaceutical and life sciences companies choose, govern and adopt AI in a way that fits regulated work, from use case discovery to everyday use.
AI can help draft, adapt and check content, but promotional material still needs approved claims, references and medical, legal and regulatory review. We design workflows that keep that review in place.
It depends on how each system is used. We help you scope each use case with your legal and compliance teams so the relevant requirements, roles and documentation are identified.
Usually with a short readiness assessment and a small number of use cases scored for value, feasibility and risk, so the first pilot is one that can move into everyday use.
No. We are based in Dublin and work with pharmaceutical and life sciences companies across Ireland and Europe, with delivery hubs in Canada and India.
A focused review of potential AI use cases, readiness and governance priorities.
